InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (6 ops.)
Insider track record
OtherDisclosed buys
6
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-49.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by COLUMN GROUP II, LP. Officer active across 2 companies, notably RAPT Therapeutics, Inc.. Cumulatively, 22 filings have been recorded. Split: 6 buys · 6 sells. Total volume traded: €25.3m. History available since 18 August 2021. The latest transaction was disclosed on 25 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations22 total
1,352,008 sharesCommon StockSEC:0000950170-24-139754:0
1,352,008 sharesCommon StockSEC:0000950170-24-139755:0
1,837 shares@ US$12.45490.1% of flowCommon StockSEC:0000899243-22-019940:0
Ideal exit: 19 Feb 2023 (T+270)
1,837 shares@ US$12.45490.1% of flowCommon StockSEC:0000899243-22-019937:0
Ideal exit: 19 Feb 2023 (T+270)
9,898 shares@ US$12.49930.5% of flowCommon StockSEC:0000899243-22-019471:0
Ideal exit: 17 Feb 2023 (T+270)
9,898 shares@ US$12.49930.5% of flowCommon StockSEC:0000899243-22-019470:0
Ideal exit: 17 Feb 2023 (T+270)
1,208,750 shares@ US$10.671547.7% of flowCommon StockSEC:0000899243-22-017787:0
Ideal exit: 4 Feb 2023 (T+270)
1,208,750 shares@ US$10.671547.7% of flowCommon StockSEC:0000899243-22-017788:0
Ideal exit: 4 Feb 2023 (T+270)
16,625 shares@ US$16.000.028% mcap50.0% of flowCommon StockSEC:0000899243-21-044836:0
16,625 shares@ US$16.0050.0% of flowCommon StockSEC:0000899243-21-044836
7,500 shares@ US$28.270.7% of flowCommon StockSEC:0000899243-21-038196
7,500 shares@ US$28.270.7% of flowCommon StockSEC:0000899243-21-038196:0
1,400 shares@ US$35.70710.2% of flowCommon StockSEC:0000899243-21-036293:0
1,400 shares@ US$35.70710.2% of flowCommon StockSEC:0000899243-21-036293
1,166,666 shares0Common StockSEC:0000899243-21-035845:0
1,166,666 shares0Common StockSEC:0000899243-21-035845
6,904 shares@ US$35.01630.8% of flowCommon StockSEC:0000899243-21-035109:0
6,904 shares@ US$35.01630.8% of flowCommon StockSEC:0000899243-21-035109
1,440 shares@ US$30.08790.1% of flowCommon StockSEC:0000899243-21-034085
1,440 shares@ US$30.08790.1% of flowCommon StockSEC:0000899243-21-034085:0
1,317,005 shares0Common StockSEC:0000899243-21-033833:0
1,317,005 shares0Common StockSEC:0000899243-21-033833
22 of 22 declarations
About COLUMN GROUP II, LP
COLUMN GROUP II, LP is a significant shareholder of RAPT Therapeutics, Inc.
